Most Recent Articles about RDY
Dr. Reddy's Reports Positive Top-Line Data on Psoriasis Drug http://www.zacks.com/stock/news/427399/dr-reddys-reports-positive-top-line-data-on-psoriasis-drug?cid=CS-ZC-FT-427399 Jun 10, 2019 - Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis.
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady http://www.zacks.com/stock/news/425808/biomarins-vimizim-wins-nod-in-china-for-rare-genetic-malady?cid=CS-ZC-FT-425808 Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
New Strong Sell Stocks for May 22nd http://www.zacks.com/stock/news/417826/new-strong-sell-stocks-for-may-22nd?cid=CS-ZC-FT-417826 May 22, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Related Companies

Name Exchange Price Mkt Cap
GLPG Galapagos NV NASDAQ $115.62 $5.94B
ALKS Alkermes plc NASDAQ $38.61 $6B
CTLT Catalent, Inc. NYSE $42.57 $6.17B
UTHR United Therapeutics Corporation NASDAQ $125.98 $5.49B
LGND Ligand Pharmaceuticals Incorporated NASDAQ $253.56 $5.35B
Sector: Health Care > Industry: Major Pharmaceuticals